SCHEMBL13610426

SCHEMBL13610426

C(=C/c1ccccc1)\CSSSc1nccc(-c2cccs2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
TSHR P16473 2/20 0.45
ALDH1A1 P00352 7/20 0.44
HSD17B10 Q99714 1/20 0.44
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 7/20 0.41
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HPGD P15428 3/20 0.39
NPC1 O15118 2/20 0.38
LMNA P02545 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
GBA1 P04062 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610420 0.78 L3MBTL1 (0.55) L3MBTL1TSHRALDH1A1RAB9AMAPT
SCHEMBL13610487 0.77 MAPT (0.52) NPSR1L3MBTL1ALDH1A1RAB9AKDM4E
SCHEMBL13610528 0.73 RAB9A (0.49) NPSR1L3MBTL1TSHRALDH1A1HSD17B10
SCHEMBL13610513 0.73 RAB9A (0.45) NPSR1L3MBTL1ALDH1A1RAB9AKDM4E
SCHEMBL13610362 0.73 RAB9A (0.48) NPSR1TSHRALDH1A1RAB9AKDM4E
SCHEMBL13610330 0.70 RAB9A (0.45) NPSR1L3MBTL1TSHRALDH1A1RAB9A
SCHEMBL13610466 0.68 ALDH1A1 (0.43) NPSR1TSHRALDH1A1HSD17B10RAB9A
SCHEMBL13610447 0.68 RAB9A (0.40) NPSR1L3MBTL1ALDH1A1RAB9AKDM4E
SCHEMBL13610383 0.68 RAB9A (0.40) NPSR1ALDH1A1RAB9AKDM4EMAPT
SCHEMBL13610404 0.68 KDM4E (0.40) NPSR1ALDH1A1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS NPSR1 379/4885L3MBTL1 884/4885TSHR 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.